{Reference Type}: Journal Article
{Title}: Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery.
{Author}: Díez-Álvarez L;Salvá-Palomeque T;Jaumandreu L;Gómez-Mariscal M;Muñoz-Negrete FJ;Rebolleda G;
{Journal}: Arch Soc Esp Oftalmol (Engl Ed)
{Volume}: 96
{Issue}: 11
{Year}: Nov 2021
暂无{DOI}: 10.1016/j.oftale.2020.12.011
{Abstract}: OBJECTIVE: To describe intracameral toxic effects of cefuroxime at a higher dose than recommended in cataract surgery.
METHODS: Retrospective study of 8 eyes of 8 patients who inadvertently received 12.5 mg/0.1 ml of intracameral cefuroxime due to a dilution error, at the end of the cataract surgery. All patients underwent a strict ophthalmology follow-up for 6 months.
RESULTS: All patients presented with a marked anterior segment inflammation with corneal oedema that resolved completely in all cases (between 5 days and 3 months). At 6 months of follow-up a statistically significant difference was found in the corneal endothelial cell density when compared with the fellow eye (P = .038), being <1000 cells/mm2 in 3 cases. Three patients (37.5%) showed early macular oedema, with subfoveal ellipsoid layer disruption in one case as a permanent sequel. One patient developed an optic neuropathy with associated afferent pupillary defect.
CONCLUSIONS: Although 1 mg/0.1 ml of intracameral cefuroxime has been shown to reduce the incidence of endophthalmitis, its overdose can have potentially toxic eye effects in both anterior and posterior segments.